Puma Biotechnology’s (PBYI) Buy Rating Reaffirmed at Stifel Nicolaus – The Cerbat Gem

Posted: June 11, 2017 at 3:42 pm


Morning Times
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at Stifel Nicolaus
The Cerbat Gem
Puma Biotechnology Inc logo Stifel Nicolaus reissued their buy rating on shares of Puma Biotechnology Inc (NYSE:PBYI) in a research note issued to investors on Monday, May 22nd. Stifel Nicolaus currently has a $88.00 target price on the ...
Puma Biotechnology Inc (PBYI) Stock Rating Reaffirmed by Citigroup IncSports Perspectives
Puma Biotechnology, Inc. (NYSE:PBYI) Shares Tick -2.44% For the WeekConcord Register
Puma Biotechnology (PBYI) Earning Somewhat Favorable Press Coverage, Study ShowsChaffey Breeze
BBNS -Petro Global News 24 -FLBC News -SEC.gov
all 14 news articles »

Read the original:
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at Stifel Nicolaus - The Cerbat Gem

Related Posts